Is the "low-hanging fruit" worth picking for antimicrobial stewardship programs?

Clinical Infectious Diseases

Volumn 55, Issue 4, 2012, Pages 587-592

  Goff, Debra A ^a   Bauer, Karri A ^a   Reed, Erica E ^a   Stevenson, Kurt B ^a,b   Taylor, Jeremy J ^a   West, Jessica E ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b Department of Obstetrics and Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CASPOFUNGIN; CHLOROTHIAZIDE; CIPROFLOXACIN; DAPTOMYCIN; ETIRACETAM; FLUCONAZOLE; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PANTOPRAZOLE; QUINOLONE DERIVATIVE; VANCOMYCIN; VORICONAZOLE;

ANTIMICROBIAL STEWARDSHIP PROGRAM; ARTICLE; COST CONTROL; DRUG FORMULATION; DRUG METABOLISM; DRUG SAFETY; FINANCE; HEALTH PROGRAM; HOSPITAL PHARMACY; HUMAN; LENGTH OF STAY; PHARMACIST; PHYSICIAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TOTAL QUALITY MANAGEMENT;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; ECONOMICS, HOSPITAL; HUMANS; INJECTIONS, INTRAVENOUS;

EID: 84864448523     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis494     Document Type: Article

References (28)

1. LaRocco A Jr. Concurrent antibiotic review programs-a role for infectious diseases specialists at small community hospitals. Clin Infect Dis 2003; 37:742-3.
2. Ohl CA, Dodds Ashley ES. Antimicrobial stewardship programs in community hospitals: the evidence base and case studies. Clin Infect Dis 2011; 53(Suppl 1):S23-8.
3. Po JL, Nguyen BQ, Carling PC. The impact of an infectious diseases specialist-directed computerized physician order entry antimicrobial stewardship program targeting linezolid use. Infect Control Hosp Epidemiol 2012; 33:434-5.
4. Septimus EJ, Owens RC Jr. Need and potential of antimicrobial stewardship in community hospitals. Clin Infect Dis 2011; 53(Suppl 1): S8-14.
5. Dellit TH, Owens RC, McGowan JE Jr, et al., Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44:159-77.
6. Policy Statement on Antimicrobial Stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infect Control Hosp Epidemiol 2012; 33:322-7.
7. John JF Jr, Fishman NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997; 24:471-85.
8. Weber RJ. Core competencies in hospital pharmacy practice: departmental financial management. Hosp Pharm 2006; 41:689-94.
9. Doloresco F, Fominaya C, Schumock GT, et al. Projecting future drug expenditures: 2011. Am J Health Syst Pharm 2011; 68:921-32.
10. Davis SL, Delgado G Jr, McKinnon PS. Pharmacoeconomic considerations associated with the use of intravenous-To-oral moxifloxacin for community-acquired pneumonia. Clin Infect Dis 2005; 41(Suppl 2): S136-43.
11. Kuti JL, Le TN, Nightingale CH, Nicolau DP, Quintiliani R. Pharmacoeconomics of a pharmacist-managed program for automatically converting levofloxacin route from i.v. to oral. Am J Health Syst Pharm 2002; 59:2209-15.
12. Paladino JA, Sperry HE, Backes JM, et al. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics. Am J Med 1991; 91:462-70.
13. Hendrickson JR, North DS. Pharmacoeconomic benefit of antibiotic step-down therapy: converting patients from intravenous ceftriaxone to oral cefpodoxime proxetil. Ann Pharmacother 1995; 29:561-5.
14. Ramirez JA, Bordon J. Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia. Arch Intern Med 2001; 161:848-50.
15. Rojo D, Pinedo A, Clavijo E, Garcia-Rodriguez A, Garcia V. Analysis of risk factors associated with nosocomial bacteraemias. J Hosp Infect 1999; 42:135-41.
16. Sevinc F, Prins JM, Koopmans RP, et al. Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital. J Antimicrob Chemother 1999; 43:601-6.
17. Mertz D, Koller M, Haller P, et al. Outcomes of early switching from intravenous to oral antibiotics on medical wards. J Antimicrob Chemother 2009; 64:188-99.
18. Lau BD, Pinto BL, Thiemann DR, Lehmann CU. Budget impact analysis of conversion from intravenous to oral medication when clinically eligible for oral intake. Clin Ther 2011; 33:1792-6.
19. Jones M, Huttner B, Madaras-Kelly K, et al. Parenteral to oral conversion of fluoroquinolones: low-hanging fruit for antimicrobial stewardship programs? Infect Control Hosp Epidemiol 2012; 33:362-7.
20. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile- Associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45:302-7.
21. Allen LV. Vancomycin hydrochloride 50 ng/ml oral solution. International Journal of Pharmaceutical Compounding 2003; 7:64.
22. White AC Jr, Atmar RL, Wilson J, Cate TR, Stager CE, Greenberg SB. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25:230-9.
23. Philmon C, Smith T, Williamson S, Goodman E. Controlling use of antimicrobials in a community teaching hospital. Infect Control Hosp Epidemiol 2006; 27:239-44.
24. Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan RPolgreen PM. Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect Control Hosp Epidemiol 2011; 32:367-74.
25. Stevenson KB, Balada-Llasat JM, Bauer K, et al. The economics of antimicrobial stewardship: the current state of the art and applying the business case model. Infect Control Hosp Epidemiol 2012; 33: 389-97.
26. Petrak RM, Sexton DJ, Butera ML, et al. The value of an infectious diseases specialist. Clin Infect Dis 2003; 36:1013-7.
27. Reduced readmissions: reform's low-hanging fruit. How can we be sure it's within our grasp? Healthc Exec 2011; 26:86, 88-6, 89.
28. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009; 360:1418-28.